Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This early-phase trial tests a new treatment for people with advanced melanoma and other solid tumors that have spread. The treatment uses the patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. Before receiving the cells, patients…
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated May 04, 2026 02:17 UTC